No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
First Canakinumab Biosimilar Approved in Russia
On 23 September 2025, GxP News reported that Russian company, Generium, has obtained registration of the first Russian biosimilar to Novartis’ Ilaris® (canakinumab).